0001209191-24-002897.txt : 20240206 0001209191-24-002897.hdr.sgml : 20240206 20240206130817 ACCESSION NUMBER: 0001209191-24-002897 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240206 DATE AS OF CHANGE: 20240206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schatzman Randall C CENTRAL INDEX KEY: 0001604763 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39988 FILM NUMBER: 24599340 MAIL ADDRESS: STREET 1: 11804 NORTH CREEK PARKWAY SOUTH CITY: BOTHELL STATE: WA ZIP: 98011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bolt Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001641281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472804636 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-665-9295 MAIL ADDRESS: STREET 1: 900 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Bolt Therapeutics, Inc. DATE OF NAME CHANGE: 20150504 5 1 doc5.xml FORM 5 SUBMISSION X0508 5 2023-12-31 0 0 0 0001641281 Bolt Biotherapeutics, Inc. BOLT 0001604763 Schatzman Randall C C/O BOLT BIOTHERAPEUTICS, INC. 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-06-06 5 P 0 2500 1.1815 A 10359 D Common Stock 2023-12-06 5 P 0 2500 0.782 A 12859 D Shares acquired under the issuer's Employee Stock Purchase Plan. /s/ William P. Quinn, Attorney-in-Fact 2024-02-06